Search events

Search by
Events by year

2016 Life Sciences Symposium (academic sessions)

May 23, 2016–May 24, 2016

Location and program details 

Bates White
1300 Eye Street NW, Suite 600 
Washington, DC 20005

Monday, May 23

8:40–9:10 a.m.

  • Chirantan Chatterjee, Indian Institute of Management
    The consumer welfare implications of governmental policies and firm strategy in markets for medicines

9:20–9:50 a.m.

  • Ben Roin, Massachusetts Institute of Technology
    Missing markets for innovation: Evidence from new uses of old drugs

10:10–10:40 a.m.

  • Tomas Philipson, University of Chicago
    Financial health economics: Hedging government risk

10:50–11:20 a.m.

  • Ernst Berndt, Massachusetts Institute of Technology
    Prescription drug spending in the US: Is the era of slow growth over?

2:30–3:00 p.m.

  • Pierre Dubois, University of Toulouse
    Estimating the benefits of cancer treatments

3:10–3:40 p.m.

  • Mark Pauly, University of Pennsylvania
    A demand-side explanation for changing R&D productivity

4:00–4:30 p.m.

  • Fred Selck, Bates White
    Case study: Irreparable harm and public interest

Tuesday,  May 24

8:30–9:00 a.m.

  • David McAdams, Duke University
    Spoilable IP

9:10–9:40 a.m.

  • Ariel Stern, Harvard University
    Market entry of biosimilars: Evidence from Europe

9:50–10:20 a.m.

  • Matthew Grennan, University of Pennsylvania
    Can big data lower health care costs?

10:40–11:10 a.m.

  • Neeraj Sood, University of Southern California
    Abby Alpert, University of California, Irvine 
    Effects of DTCA on drug utilization and adherence

11:20–11:50 a.m.

  • Frank Lichtenberg, Columbia University
    Listen to your doctor, or else!: Medication under-use and overuse and long-term health outcomes of Danish diabetes patients

1:00–1:30 p.m.

  • David Grabowski, Harvard Medical School
    The value of new anticancer drugs

1:40–2:10 p.m.

  • Ashley Swanson, University of Pennsylvania
    Pass-through in a highly regulated supply chain: The who, what, and when of the US drug market

2:30–3:00 p.m.

  • Aaron Yelowitz, University of Kentucky
    Evaluating the effects of the False Claims Act on Medicaid expenditure growth, using state-level data

3:10–3:40 p.m.

  • Bill Comanor, University of California, Los Angeles
    Ted Frech, University of California, Santa Barbara 
    Are generic pharmacutical prices increasing at a staggering rate?

Registration
If you are interested in attending, please email Ngar Eldredge.